This approach has been employed to characterise tumours as inflamed or non-inflamed using the CD8 cell signature.157 The algorithm was trained by combining the contrast-enhanced CT scans of 135 patients with advanced solid tumours from the MOSCATO trial, with respective RNA-sequencing data of the CD8B gene. Here, CD8A is linked to neoplasm.